表紙
市場調査レポート

網膜症:世界の治験レビュー

Retinopathy Global Clinical Trials Review, H2, 2014

発行 GlobalData 商品コード 322181
出版日 ページ情報 英文 68 Pages
即納可能
価格
本日の銀行送金レート: 1USD=106.12円で換算しております。
Back to Top
網膜症:世界の治験レビュー Retinopathy Global Clinical Trials Review, H2, 2014
出版日: 2014年12月31日 ページ情報: 英文 68 Pages
概要

当レポートでは、網膜症の臨床試験に関連する基本情報やデータを提供しており、試験件数および被験者の募集状況、段階別の動向、臨床試験を実施している主な製薬企業および研究機関のプロファイルなどをまとめています。

イントロダクション

  • 網膜症
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋地域の主要5ヶ国における治験件数
    • 欧州の主要5ヶ国における治験件数
    • 北米の主要国における治験件数
    • 中東・アフリカの主要国における治験件数
    • 中南米の主要国における治験件数

G7諸国での治験件数:眼科疾患の治験における網膜症の割合

G7諸国における段階別の治験件数

G7諸国での治験件数:進捗状況別

E7諸国での治験件数:眼科疾患の治験における網膜症の割合

E7諸国における段階別の治験件数

E7諸国での治験件数:進捗状況別

段階別の治験件数

  • 進行中の治験:段階別

進捗状況別の治験件数

治験の目標の達成状況

未完了の治験件数

一定期間に採用された被験者

スポンサーの種類別の治験件数

有望なスポンサー

網膜症治療薬の治験に携わっている主要企業

有望な薬剤

治験のプロファイル

  • 主要企業の治験の概要
    • SIFI S.p.A
    • Shire Plc
    • Mednax, Inc.
    • Insmed Incorporated
    • Gene Signal International SA
    • EyeGene, Inc.
    • AstraZeneca PLC
  • 代表的な研究機関・病院の治験の概要
    • National Eye Institute
    • Eunice Kennedy Shriver National Institute of Child Health and Human Development
    • 名古屋大学
    • Manhattan Eye Ear & Throat Hospital
    • Azienda Ospedaliero-Universitaria Meyer
    • Dr. Sami Ulus Children's Hospital
    • Weill Cornell Medical College
    • Islamic Azad University of Tabriz
    • The Children's Hospital of Philadelphia
    • Kansai Medical University

5つの代表的な治験のプロファイル

付録

目次
Product Code: GDHC2518CTIDB

GlobalData's clinical trial report, "Retinopathy Global Clinical Trials Review, H2, 2014" provides data on the Retinopathy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Retinopathy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Retinopathy. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Retinopathy
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Retinopathy to Ophthalmology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Retinopathy to Ophthalmology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Retinopathy
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Retinopathy Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • SIFI S.p.A
      • Clinical Trial Overview of SIFI S.p.A
      • Shire Plc
      • Clinical Trial Overview of Shire Plc
      • Mednax, Inc.
      • Clinical Trial Overview of Mednax, Inc.
      • Insmed Incorporated
      • Clinical Trial Overview of Insmed Incorporated
      • Gene Signal International SA
      • Clinical Trial Overview of Gene Signal International SA
      • EyeGene, Inc.
      • Clinical Trial Overview of EyeGene, Inc.
      • AstraZeneca PLC
      • Clinical Trial Overview of AstraZeneca PLC
    • Clinical Trial Overview of Top Institutes / Government
      • National Eye Institute
      • Clinical Trial Overview of National Eye Institute
      • Eunice Kennedy Shriver National Institute of Child Health and Human Development
      • Clinical Trial Overview of Eunice Kennedy Shriver National Institute of Child Health and Human Development
      • Nagoya University
      • Clinical Trial Overview of Nagoya University
      • Manhattan Eye Ear & Throat Hospital
      • Clinical Trial Overview of Manhattan Eye Ear & Throat Hospital
      • Azienda Ospedaliero-Universitaria Meyer
      • Clinical Trial Overview of Azienda Ospedaliero-Universitaria Meyer
      • Dr. Sami Ulus Children's Hospital
      • Clinical Trial Overview of Dr. Sami Ulus Children's Hospital
      • Weill Cornell Medical College
      • Clinical Trial Overview of Weill Cornell Medical College
      • Islamic Azad University of Tabriz
      • Clinical Trial Overview of Islamic Azad University of Tabriz
      • The Children's Hospital of Philadelphia
      • Clinical Trial Overview of The Children's Hospital of Philadelphia
      • Kansai Medical University
      • Clinical Trial Overview of Kansai Medical University
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Retinopathy Therapeutics, Global, Clinical Trials by Region, 2014*
  • Retinopathy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Retinopathy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Retinopathy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Retinopathy Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Retinopathy Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Retinopathy Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Retinopathy Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Retinopathy to Ophthalmology Clinical Trials, G7 Countries (%), 2014*
  • Retinopathy Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Retinopathy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Retinopathy to Ophthalmology Clinical Trials, E7 Countries (%), 2014*
  • Retinopathy Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Retinopathy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Retinopathy Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Retinopathy Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Retinopathy Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Retinopathy Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Retinopathy Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Retinopathy Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Retinopathy Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Retinopathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Retinopathy Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Retinopathy Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Retinopathy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Retinopathy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Retinopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by SIFI S.p.A, 2014*
  • Retinopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Shire Plc, 2014*
  • Retinopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Mednax, Inc., 2014*
  • Retinopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Insmed Incorporated, 2014*
  • Retinopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Gene Signal International SA, 2014*
  • Retinopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by EyeGene, Inc., 2014*
  • Retinopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014*
  • Retinopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by National Eye Institute, 2014*
  • Retinopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Eunice Kennedy Shriver National Institute of Child Health and Human Development, 2014*
  • Retinopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Nagoya University, 2014*
  • Retinopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Manhattan Eye Ear & Throat Hospital, 2014*
  • Retinopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Azienda Ospedaliero-Universitaria Meyer, 2014*
  • Retinopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Dr. Sami Ulus Children's Hospital, 2014*
  • Retinopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Weill Cornell Medical College, 2014*
  • Retinopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Islamic Azad University of Tabriz, 2014*
  • Retinopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by The Children's Hospital of Philadelphia, 2014*
  • Retinopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Kansai Medical University, 2014*

List of Figures

  • Retinopathy Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Retinopathy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Retinopathy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Retinopathy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Retinopathy Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Retinopathy Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Retinopathy Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014*
  • Proportion of Retinopathy to Ophthalmology Clinical Trials, G7 Countries (%), 2014*
  • Retinopathy Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Retinopathy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Retinopathy to Ophthalmology Clinical Trials, E7 Countries (%), 2014*
  • Retinopathy Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Retinopathy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Retinopathy Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Retinopathy Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Retinopathy Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Retinopathy Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Retinopathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Retinopathy Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Retinopathy Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Retinopathy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Retinopathy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top